Assessing the effects of therapeutic combinations on SARS-CoV-2 infected patient outcomes: A big data approach

BACKGROUND: The COVID-19 pandemic has demonstrated the need for efficient and comprehensive, simultaneous assessment of multiple combined novel therapies for viral infection across the range of illness severity. Randomized Controlled Trials (RCT) are the gold standard by which efficacy of therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Moradi, Hamidreza, Bunnell, H. Timothy, Price, Bradley S., Khodaverdi, Maryam, Vest, Michael T., Porterfield, James Z., Anzalone, Alfred J., Santangelo, Susan L., Kimble, Wesley, Harper, Jeremy, Hillegass, William B., Hodder, Sally L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997963/
https://www.ncbi.nlm.nih.gov/pubmed/36893086
http://dx.doi.org/10.1371/journal.pone.0282587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997963/
https://www.ncbi.nlm.nih.gov/pubmed/36893086
http://dx.doi.org/10.1371/journal.pone.0282587

Ejemplares similares